GAIA BioMedicine
Fukuoka
About GAIA BioMedicine
GAIA BioMedicine, Inc., a technology-driven biopharmaceutical firm specialized in cell treatments and immunotherapies for intractable malignancies, was created in 2015 as a spin-off venture of Kyushu University. The firm name, GAIA, reflects the company's aim and vision as we fight intractable diseases with the strength of genes and the immune system, as the rod of Asclepius, the Greek god of medicine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $18.8M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2021)
- Website: gaia-biomed.com
- Phone: +81-92-642-4708
Industries & Categories
Biotechnology, Management Consulting, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/gaia-biomedicine-99724 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.